000 01362 a2200397 4500
005 20250514195648.0
264 0 _c20041217
008 200412s 0 0 eng d
022 _a1536-8599
024 7 _a10.1089/1536859041224280
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGarrido, Greta
245 0 0 _a7A7 MAb: a new tool for the pre-clinical evaluation of EGFR-based therapies.
_h[electronic resource]
260 _bHybridoma and hybridomics
_cJun 2004
300 _a168-75 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_ximmunology
650 0 4 _aAntibody Specificity
650 0 4 _aCell Line, Tumor
650 0 4 _aCross Reactions
650 0 4 _aDrug Evaluation, Preclinical
_xinstrumentation
650 0 4 _aErbB Receptors
_xantagonists & inhibitors
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
700 1 _aSanchez, Belinda
700 1 _aRodriguez, Hilda Maria
700 1 _aLorenzano, Pablo
700 1 _aAlonso, Daniel
700 1 _aFernandez, Luis Enrique
773 0 _tHybridoma and hybridomics
_gvol. 23
_gno. 3
_gp. 168-75
856 4 0 _uhttps://doi.org/10.1089/1536859041224280
_zAvailable from publisher's website
999 _c15011379
_d15011379